Harbor Capital Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,851
| Closed | -$253K | – | 1423 |
|
|
2024
Q4 | $253K | Buy |
3,851
+93
| +2% | +$6.11K | 0.01% | 632 |
|
|
2024
Q3 | $264K | Buy |
3,758
+15
| +0.4% | +$1.05K | 0.01% | 643 |
|
|
2024
Q2 | $308K | Buy |
3,743
+11
| +0.3% | +$905 | 0.02% | 605 |
|
|
2024
Q1 | $326K | Buy |
3,732
+373
| +11% | +$32.6K | 0.04% | 502 |
|
|
2023
Q4 | $324K | Buy |
3,359
+1
| +0% | +$96 | 0.06% | 306 |
|
|
2023
Q3 | $297K | Hold |
3,358
| – | – | 0.06% | 308 |
|
|
2023
Q2 | $291K | Hold |
3,358
| – | – | 0.06% | 323 |
|
|
2023
Q1 | $327K | Buy |
+3,358
| New | +$327K | 0.09% | 177 |
|